Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of [14C]TPN171H in Healthy Male Subjects
NCT04655872Phase 1Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of TPN171H in pulmonary arterial hypertension (PAH) and erectile dysfunction (ED), sponsored by Vigonvita Life Sciences. Primary endpoints: Maximum observed plasma concentration, Time to Cmax and 3 more. Started Nov 2020; status: completed.
02
Drugs
TPN171H
03
Conditions
pulmonary arterial hypertension (PAH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04655872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655872.